RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos

Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Acadia Gets European Commission Nod for Daybu in Rett Syndrome

Here's Why You Should Add ACET Stock to Your Portfolio Now

RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy

1 Stock Under $50 with Solid Fundamentals and 2 Facing Challenges

JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer

BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program

AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study